{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:57:46Z","timestamp":1792799866479,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["(PI17\/01093, PI17\/01193, PI20\/00763, CP15\/00129, CPII20\/00022"],"award-info":[{"award-number":["(PI17\/01093, PI17\/01193, PI20\/00763, CP15\/00129, CPII20\/00022"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["SAF2017-84777-R, PID2020-113238RB-I00"],"award-info":[{"award-number":["SAF2017-84777-R, PID2020-113238RB-I00"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic kidney disease (CKD) is associated with increased propensity for arrhythmias. In this context, ventricular repolarization alterations have been shown to predispose to fatal arrhythmias and sudden cardiac death. Between mineral bone disturbances in CKD patients, increased fibroblast growth factor (FGF) 23 and decreased Klotho are emerging as important effectors of cardiovascular disease. However, the relationship between imbalanced FGF23-Klotho axis and the development of cardiac arrhythmias in CKD remains unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We carried out a translational approach to study the relationship between the FGF23\u2013Klotho signaling axis and acquired long QT syndrome in CKD-associated uremia. FGF23 levels and cardiac repolarization dynamics were analyzed in patients with dialysis-dependent CKD and in uremic mouse models of 5\/6 nephrectomy (Nfx) and Klotho deficiency (hypomorphism), which show very high systemic FGF23 levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients in the top quartile of FGF23 levels had a higher occurrence of very long QT intervals (&gt;\u2009490\u2009ms) than peers in the lowest quartile. Experimentally, FGF23 induced QT prolongation in healthy mice. Similarly, alterations in cardiac repolarization and QT prolongation were observed in Nfx mice and in Klotho hypomorphic mice. QT prolongation in Nfx mice was explained by a significant decrease in the fast transient outward potassium (K<jats:sup>+<\/jats:sup>) current (<jats:italic>I<\/jats:italic><jats:sub><jats:italic>tof<\/jats:italic><\/jats:sub>), caused by the downregulation of K<jats:sup>+<\/jats:sup> channel 4.2 subunit (<jats:italic>Kv4.2<\/jats:italic>) expression. <jats:italic>Kv4.2<\/jats:italic> expression was also significantly reduced in ventricular cardiomyocytes exposed to FGF23. Enhancing Klotho availability prevented both long QT prolongation and reduced <jats:italic>I<\/jats:italic><jats:sub><jats:italic>tof<\/jats:italic><\/jats:sub> current. Likewise, administration of recombinant Klotho blocked the downregulation of <jats:italic>Kv4.2<\/jats:italic> expression in Nfx mice and in FGF23-exposed cardiomyocytes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The FGF23\u2013Klotho axis emerges as a new therapeutic target to prevent acquired long QT syndrome in uremia by minimizing the predisposition to potentially fatal ventricular arrhythmias and sudden cardiac death in patients with CKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12916-021-02209-9","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:03:32Z","timestamp":1642557812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23"],"prefix":"10.1186","volume":"20","author":[{"given":"Jos\u00e9 Alberto","family":"Navarro-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Salguero-Bodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gonz\u00e1lez-Lafuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mart\u00edn-Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rodr\u00edguez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Bada-Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelina","family":"M\u00e9rida-Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Praga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kuro-O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Fern\u00e1ndez-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-0915","authenticated-orcid":false,"given":"Gema","family":"Ruiz-Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"issue":"13","key":"2209_CR1","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305. https:\/\/doi.org\/10.1056\/NEJMoa041031.","journal-title":"N Engl J Med"},{"issue":"6","key":"2209_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ki.2011.223","volume":"80","author":"CA Herzog","year":"2011","unstructured":"Herzog CA, Asinger RW, Berger AK, Charytan DM, D\u00edez J, Hart RG, et al. Cardiovascular disease in chronic kidney disease. a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011;80(6):572\u201386. https:\/\/doi.org\/10.1038\/ki.2011.223.","journal-title":"Kidney Int"},{"issue":"10041","key":"2209_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0140-6736(16)30508-6","volume":"388","author":"C Wanner","year":"2016","unstructured":"Wanner C, Amann K, Shoji T. The heart and vascular system in dialysis. Lancet. 2016;388(10041):276\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(16)30508-6.","journal-title":"Lancet"},{"issue":"8","key":"2209_CR4","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208\u201318. https:\/\/doi.org\/10.1097\/01.ASN.0000133041.27682.A2.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2209_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1681\/ASN.2017070772","volume":"29","author":"T Isakova","year":"2018","unstructured":"Isakova T, Cai X, Lee J, Xie D, Wang X, Mehta R, et al. Longitudinal FGF23 trajectories and mortality in patients with CKD. J Am Soc Nephrol. 2018;29(2):579\u201390. https:\/\/doi.org\/10.1681\/ASN.2017070772.","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"2209_CR6","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011;305(23):2432\u20139. https:\/\/doi.org\/10.1001\/jama.2011.826.","journal-title":"JAMA"},{"issue":"6","key":"2209_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Guti\u00e9rrez","year":"2008","unstructured":"Guti\u00e9rrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359(6):584\u201392. https:\/\/doi.org\/10.1056\/NEJMoa0706130.","journal-title":"N Engl J Med"},{"issue":"7","key":"2209_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/ki.2012.176","volume":"82","author":"M Wolf","year":"2012","unstructured":"Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int. 2012;82(7):737\u201347. https:\/\/doi.org\/10.1038\/ki.2012.176.","journal-title":"Kidney Int"},{"issue":"7","key":"2209_CR9","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1681\/ASN.2017121334","volume":"29","author":"A Marthi","year":"2018","unstructured":"Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, et al. Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: a meta-analysis. Journal of the American Society of Nephrology. 2018;29(7):2015\u201327. https:\/\/doi.org\/10.1681\/ASN.2017121334.","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7120","key":"2209_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444(7120):770\u20134. https:\/\/doi.org\/10.1038\/nature05315.","journal-title":"Nature"},{"issue":"6655","key":"2209_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45\u201351. https:\/\/doi.org\/10.1038\/36285.","journal-title":"Nature"},{"issue":"50","key":"2209_CR12","doi-asserted-by":"publisher","first-page":"19796","DOI":"10.1073\/pnas.0709805104","volume":"104","author":"CD Chen","year":"2007","unstructured":"Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A. 2007;104(50):19796\u2013801. https:\/\/doi.org\/10.1073\/pnas.0709805104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2209_CR13","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1681\/ASN.2014040325","volume":"26","author":"J Xie","year":"2015","unstructured":"Xie J, Yoon J, An SW, Kuro-o M, Huang CL. Soluble Klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate. J Am Soc Nephrol. 2015;26(5):1150\u201360. https:\/\/doi.org\/10.1681\/ASN.2014040325.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2209_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/ndt\/gfs460","volume":"28","author":"I Pavik","year":"2013","unstructured":"Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, et al. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant. 2013;28(2):352\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfs460.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2209_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ndt\/gfs451","volume":"28","author":"JP Kooman","year":"2013","unstructured":"Kooman JP, Broers NJ, Usvyat L, Thijssen S, van der Sande FM, Cornelis T, et al. Out of control: accelerated aging in uremia. Nephrol Dial Transplant. 2013;28(1):48\u201354. https:\/\/doi.org\/10.1093\/ndt\/gfs451.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2209_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1053\/j.ajkd.2012.11.051","volume":"62","author":"P Stenvinkel","year":"2013","unstructured":"Stenvinkel P, Larsson TE. Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis. 2013;62(2):339\u201351. https:\/\/doi.org\/10.1053\/j.ajkd.2012.11.051.","journal-title":"Am J Kidney Dis"},{"issue":"5 Suppl 3","key":"2209_CR17","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112\u20139. https:\/\/doi.org\/10.1053\/ajkd.1998.v32.pm9820470.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2209_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mcna.2011.11.003","volume":"96","author":"R Dhingra","year":"2012","unstructured":"Dhingra R, Vasan RS. Age as a risk factor. Med Clin North Am. 2012;96(1):87\u201391. https:\/\/doi.org\/10.1016\/j.mcna.2011.11.003.","journal-title":"Med Clin North Am"},{"issue":"4","key":"2209_CR19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2215\/CJN.09350915","volume":"11","author":"DM Charytan","year":"2016","unstructured":"Charytan DM, Foley R, McCullough PA, Rogers JD, Zimetbaum P, Herzog CA, et al. Committees MIa: Arrhythmia and sudden death in hemodialysis patients: protocol and baseline characteristics of the monitoring in dialysis study. Clin J Am Soc Nephrol. 2016;11(4):721\u201334. https:\/\/doi.org\/10.2215\/CJN.09350915.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"2209_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200756","volume":"13","author":"M Coll","year":"2018","unstructured":"Coll M, Ferrer-Costa C, Pich S, Allegue C, Rodrigo E, Fern\u00e1ndez-Fresnedo G, et al. Martinez de Francisco AL, Ortega I et al: Role of genetic and electrolyte abnormalities in prolonged QTc interval and sudden cardiac death in end-stage renal disease patients. PLoS One. 2018;13(7):e0200756. https:\/\/doi.org\/10.1371\/journal.pone.0200756.","journal-title":"PLoS One"},{"issue":"16","key":"2209_CR21","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1053\/euhj.2001.2824","volume":"22","author":"SG Priori","year":"2001","unstructured":"Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22(16):1374\u2013450. https:\/\/doi.org\/10.1053\/euhj.2001.2824.","journal-title":"Eur Heart J"},{"issue":"2","key":"2209_CR22","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.ijcard.2007.11.070","volume":"130","author":"S Patan\u00e8","year":"2008","unstructured":"Patan\u00e8 S, Marte F, Di Bella G, Curr\u00f2 A, Coglitore S. QT interval prolongation, torsade de pointes and renal disease. Int J Cardiol. 2008;130(2):e71\u20133. https:\/\/doi.org\/10.1016\/j.ijcard.2007.11.070.","journal-title":"Int J Cardiol"},{"issue":"6","key":"2209_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/nep.12808","volume":"22","author":"HL Kuo","year":"2017","unstructured":"Kuo HL, Liu YL, Liang CC, Chang CT, Wang SM, Liu JH, et al. Prolonged QT interval is linked to all-cause and cardiac mortality in chronic peritoneal dialysis patients. Nephrology (Carlton). 2017;22(6):436\u201340. https:\/\/doi.org\/10.1111\/nep.12808.","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"2209_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209297","volume":"14","author":"Y Matsumoto","year":"2019","unstructured":"Matsumoto Y, Mori Y, Kageyama S, Arihara K, Sato H, Nagata K, et al. Changes in QTc interval in long-term hemodialysis patients. PLoS One. 2019;14(1):e0209297. https:\/\/doi.org\/10.1371\/journal.pone.0209297.","journal-title":"PLoS One"},{"issue":"7","key":"2209_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/europace\/eus412","volume":"15","author":"S Genovesi","year":"2013","unstructured":"Genovesi S, Rossi E, Nava M, Riva H, De Franceschi S, Fabbrini P, et al. A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval. Europace. 2013;15(7):1025\u201333. https:\/\/doi.org\/10.1093\/europace\/eus412.","journal-title":"Europace"},{"issue":"4","key":"2209_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1053\/ajkd.2002.32005","volume":"39","author":"ER Beaubien","year":"2002","unstructured":"Beaubien ER, Pylypchuk GB, Akhtar J, Biem HJ. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis. 2002;39(4):834\u201342. https:\/\/doi.org\/10.1053\/ajkd.2002.32005.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2209_CR27","first-page":"590","volume":"4","author":"MR Khosoosi Niaki","year":"2013","unstructured":"Khosoosi Niaki MR, Saravi M, Oliaee F, Akbari R, Noorkhomami S, Bozorgi Rad SH, et al. Changes in QT interval before and after hemodialysis. Caspian J Intern Med. 2013;4(1):590\u20134.","journal-title":"Caspian J Intern Med"},{"issue":"7","key":"2209_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/clc.22277","volume":"37","author":"KA Sherif","year":"2014","unstructured":"Sherif KA, Abo-Salem E, Panikkath R, Nusrat M, Tuncel M. Cardiac repolarization abnormalities among patients with various stages of chronic kidney disease. Clin Cardiol. 2014;37(7):417\u201321. https:\/\/doi.org\/10.1002\/clc.22277.","journal-title":"Clin Cardiol"},{"issue":"15","key":"2209_CR29","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","volume":"142","author":"JE Tisdale","year":"2020","unstructured":"Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, et al. Nursing AHACPCotCoCCaCoCaS: Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation. 2020;142(15):e214\u201333. https:\/\/doi.org\/10.1161\/CIR.0000000000000905.","journal-title":"Circulation"},{"key":"2209_CR30","doi-asserted-by":"crossref","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G et al: 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015, 36(41):2793-2867.","DOI":"10.1093\/eurheartj\/ehv316"},{"issue":"21","key":"2209_CR31","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.118.033943","volume":"138","author":"AS Vink","year":"2018","unstructured":"Vink AS, Neumann B, Lieve KVV, Sinner MF, Hofman N, El Kadi S, et al. Determination and Interpretation of the QT Interval. Circulation. 2018;138(21):2345\u201358. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.033943.","journal-title":"Circulation"},{"key":"2209_CR32","doi-asserted-by":"crossref","unstructured":"Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, Gorgels A, Hancock EW, Josephson M, Kligfield P et al: AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009, 53(11):982-991.","DOI":"10.1161\/CIRCULATIONAHA.108.191096"},{"issue":"8","key":"2209_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1540-8167.1996.tb00583.x","volume":"7","author":"B Surawicz","year":"1996","unstructured":"Surawicz B. Will QT dispersion play a role in clinical decision-making? J Cardiovasc Electrophysiol. 1996;7(8):777\u201384. https:\/\/doi.org\/10.1111\/j.1540-8167.1996.tb00583.x.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"4","key":"2209_CR34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/europace\/euw430","volume":"20","author":"TM Rosenthal","year":"2018","unstructured":"Rosenthal TM, Masvidal D, Abi Samra FM, Bernard ML, Khatib S, Polin GM, et al. Optimal method of measuring the T-peak to T-end interval for risk stratification in primary prevention. Europace. 2018;20(4):698\u2013705. https:\/\/doi.org\/10.1093\/europace\/euw430.","journal-title":"Europace"},{"issue":"20","key":"2209_CR35","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1111\/bph.15235","volume":"177","author":"JA Navarro-Garc\u00eda","year":"2020","unstructured":"Navarro-Garc\u00eda JA, Rueda A, Romero-Garc\u00eda T, Aceves-Ripoll J, Rodr\u00edguez-S\u00e1nchez E, Gonz\u00e1lez-Lafuente L, et al. Enhanced Klotho availability protects against cardiac dysfunction induced by uraemic cardiomyopathy by regulating Ca. Br J Pharmacol. 2020;177(20):4701\u201319. https:\/\/doi.org\/10.1111\/bph.15235.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2209_CR36","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.kint.2016.10.034","volume":"91","author":"MC Hu","year":"2017","unstructured":"Hu MC, Shi M, Gillings N, Flores B, Takahashi M, Kuro-O M, et al. Recombinant \u03b1-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. Kidney Int. 2017;91(5):1104\u201314. https:\/\/doi.org\/10.1016\/j.kint.2016.10.034.","journal-title":"Kidney Int"},{"issue":"3","key":"2209_CR37","doi-asserted-by":"publisher","first-page":"H747","DOI":"10.1152\/ajpheart.1998.274.3.H747","volume":"274","author":"GF Mitchell","year":"1998","unstructured":"Mitchell GF, Jeron A, Koren G. Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol. 1998;274(3):H747\u201351. https:\/\/doi.org\/10.1152\/ajpheart.1998.274.3.H747.","journal-title":"Am J Physiol"},{"issue":"4","key":"2209_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1085\/jgp.201511366","volume":"146","author":"G Ruiz-Hurtado","year":"2015","unstructured":"Ruiz-Hurtado G, Li L, Fern\u00e1ndez-Velasco M, Rueda A, Lefebvre F, Wang Y, et al. Reconciling depressed Ca2+ sparks occurrence with enhanced RyR2 activity in failing mice cardiomyocytes. J Gen Physiol. 2015;146(4):295\u2013306. https:\/\/doi.org\/10.1085\/jgp.201511366.","journal-title":"J Gen Physiol"},{"issue":"14","key":"2209_CR39","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1111\/bph.15048","volume":"177","author":"M Tamayo","year":"2020","unstructured":"Tamayo M, Mart\u00edn-Nunes L, Val-Blasco A. G M-Piedras MJ, Navarro-Garc\u00eda JA, Lage E, Prieto P, Ruiz-Hurtado G, Fern\u00e1ndez-Velasco M, Delgado C: Beneficial effects of paricalcitol on cardiac dysfunction and remodelling in a model of established heart failure. Br J Pharmacol. 2020;177(14):3273\u201390. https:\/\/doi.org\/10.1111\/bph.15048.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"2209_CR40","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/chd.12847","volume":"14","author":"JT Vehmeijer","year":"2019","unstructured":"Vehmeijer JT, Koyak Z, Vink AS, Budts W, Harris L, Silversides CK, et al. Prolonged T peak - T end interval is a risk factor for sudden cardiac death in adults with congenital heart disease. Congenit Heart Dis. 2019;14(6):952\u20137. https:\/\/doi.org\/10.1111\/chd.12847.","journal-title":"Congenit Heart Dis"},{"issue":"49","key":"2209_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018080","volume":"98","author":"C Xue","year":"2019","unstructured":"Xue C, Hua W, Cai C, Ding LG, Niu HX, Fan XH, et al. Predictive value of Tpeak-Tend interval for ventricular arrhythmia and mortality in heart failure patients with an implantable cardioverter-defibrillator: a cohort study. Medicine (Baltimore). 2019;98(49):e18080. https:\/\/doi.org\/10.1097\/MD.0000000000018080.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2209_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF00261969","volume":"16","author":"RF Gagnon","year":"1988","unstructured":"Gagnon RF, Gallimore B. Characterization of a mouse model of chronic uremia. Urol Res. 1988;16(2):119\u201326. https:\/\/doi.org\/10.1007\/BF00261969.","journal-title":"Urol Res"},{"issue":"6","key":"2209_CR43","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1681\/ASN.2016080828","volume":"28","author":"DA Drew","year":"2017","unstructured":"Drew DA, Katz R, Kritchevsky S, Ix J, Shlipak M, Guti\u00e9rrez OM, et al. Association between soluble Klotho and change in kidney function: the health aging and body composition study. J Am Soc Nephrol. 2017;28(6):1859\u201366. https:\/\/doi.org\/10.1681\/ASN.2016080828.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2209_CR44","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011;121(11):4393\u2013408. https:\/\/doi.org\/10.1172\/JCI46122.","journal-title":"J Clin Invest"},{"issue":"11","key":"2209_CR45","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1093\/ndt\/gfy392","volume":"34","author":"JA Navarro-Garc\u00eda","year":"2019","unstructured":"Navarro-Garc\u00eda JA, Delgado C, Fern\u00e1ndez-Velasco M, Val-Blasco A, Rodr\u00edguez-S\u00e1nchez E, Aceves-Ripoll J, et al. Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes. Nephrol Dial Transplant. 2019;34(11):1864\u201375. https:\/\/doi.org\/10.1093\/ndt\/gfy392.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2209_CR46","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1113\/expphysiol.2007.040659","volume":"93","author":"T Banyasz","year":"2008","unstructured":"Banyasz T, Lozinskiy I, Payne CE, Edelmann S, Norton B, Chen B, et al. Transformation of adult rat cardiac myocytes in primary culture. Exp Physiol. 2008;93(3):370\u201382. https:\/\/doi.org\/10.1113\/expphysiol.2007.040659.","journal-title":"Exp Physiol"},{"key":"2209_CR47","doi-asserted-by":"crossref","unstructured":"Kooman JP, van der Sande FM, Leunissen KM: Kidney disease and aging: a reciprocal relation. Exp Gerontol 2017, 87(Pt B):156-159.","DOI":"10.1016\/j.exger.2016.02.003"},{"issue":"1","key":"2209_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40520-015-0371-y","volume":"28","author":"Y Zeng","year":"2016","unstructured":"Zeng Y, Wang PH, Zhang M, Du JR. Aging-related renal injury and inflammation are associated with downregulation of Klotho and induction of RIG-I\/NF-\u03baB signaling pathway in senescence-accelerated mice. Aging Clin Exp Res. 2016;28(1):69\u201376. https:\/\/doi.org\/10.1007\/s40520-015-0371-y.","journal-title":"Aging Clin Exp Res"},{"issue":"9623","key":"2209_CR49","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0140-6736(08)60313-X","volume":"371","author":"AD Sniderman","year":"2008","unstructured":"Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008;371(9623):1547\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(08)60313-X.","journal-title":"Lancet"},{"issue":"6","key":"2209_CR50","first-page":"1","volume":"68","author":"M Heron","year":"2019","unstructured":"Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68(6):1\u201377.","journal-title":"Natl Vital Stat Rep"},{"issue":"7","key":"2209_CR51","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1681\/ASN.2005101085","volume":"17","author":"M Tonelli","year":"2006","unstructured":"Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17(7):2034\u201347. https:\/\/doi.org\/10.1681\/ASN.2005101085.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2209_CR52","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jelectrocard.2016.07.016","volume":"49","author":"D Banerjee","year":"2016","unstructured":"Banerjee D. Sudden cardiac death in haemodialysis: clinical epidemiology and mechanisms. J Electrocardiol. 2016;49(6):843\u20137. https:\/\/doi.org\/10.1016\/j.jelectrocard.2016.07.016.","journal-title":"J Electrocardiol"},{"issue":"11","key":"2209_CR53","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jacc.2021.01.028","volume":"77","author":"AC Lai","year":"2021","unstructured":"Lai AC, Bienstock SW, Sharma R, Skorecki K, Beerkens F, Samtani R, et al. A personalized approach to chronic kidney disease and cardiovascular disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2021;77(11):1470\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2021.01.028.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2209_CR54","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.2215\/CJN.04310416","volume":"11","author":"E Verde","year":"2016","unstructured":"Verde E. P\u00e9rez de Prado A, L\u00f3pez-G\u00f3mez JM, Quiroga B, Goicoechea M, Garc\u00eda-Prieto A, Torres E, Reque J, Lu\u00f1o J: Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2016;11(12):2210\u20137. https:\/\/doi.org\/10.2215\/CJN.04310416.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2209_CR55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fendo.2018.00333","volume":"9","author":"M Leifheit-Nestler","year":"2018","unstructured":"Leifheit-Nestler M, Richter B, Basaran M, Nespor J, Vogt I, Alesutan I, et al. Impact of altered mineral metabolism on pathological cardiac remodeling in elevated fibroblast growth factor 23. Front Endocrinol (Lausanne). 2018;9:333. https:\/\/doi.org\/10.3389\/fendo.2018.00333.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2209_CR56","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/j.1532-5415.2011.03558.x","volume":"59","author":"RD Semba","year":"2011","unstructured":"Semba RD, Cappola AR, Sun K, Bandinelli S, Dalal M, Crasto C, et al. Plasma Klotho and cardiovascular disease in adults. J Am Geriatr Soc. 2011;59(9):1596\u2013601. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03558.x.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"2209_CR57","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/gerona\/glr058","volume":"66","author":"RD Semba","year":"2011","unstructured":"Semba RD, Cappola AR, Sun K, Bandinelli S, Dalal M, Crasto C, et al. Plasma Klotho and mortality risk in older community-dwelling adults. J Gerontol A Biol Sci Med Sci. 2011;66(7):794\u2013800. https:\/\/doi.org\/10.1093\/gerona\/glr058.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"2209_CR58","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.08.017","volume":"242","author":"VM Brandenburg","year":"2015","unstructured":"Brandenburg VM, Kleber ME, Vervloet MG, Larsson TE, Tomaschitz A, Pilz S, et al. SOLUBLE Klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis. 2015;242(2):483\u20139. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.017.","journal-title":"Atherosclerosis"},{"key":"2209_CR59","doi-asserted-by":"publisher","first-page":"632260","DOI":"10.3389\/fphys.2021.632260","volume":"12","author":"S V\u00e1zquez-S\u00e1nchez","year":"2021","unstructured":"V\u00e1zquez-S\u00e1nchez S, Poveda J, Navarro-Garc\u00eda JA, Gonz\u00e1lez-Lafuente L, Rodr\u00edguez-S\u00e1nchez E, Ruilope LM, et al. An overview of FGF-23 as a novel candidate biomarker of cardiovascular risk. Front Physiol. 2021;12:632260. https:\/\/doi.org\/10.3389\/fphys.2021.632260.","journal-title":"Front Physiol"},{"issue":"6","key":"2209_CR60","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","volume":"22","author":"A Grabner","year":"2015","unstructured":"Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, et al. Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy. Cell Metab. 2015;22(6):1020\u201332. https:\/\/doi.org\/10.1016\/j.cmet.2015.09.002.","journal-title":"Cell Metab"},{"issue":"7","key":"2209_CR61","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","volume":"31","author":"M Leifheit-Nestler","year":"2016","unstructured":"Leifheit-Nestler M, Gro\u00dfe Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, et al. Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. Nephrol Dial Transplant. 2016;31(7):1088\u201399. https:\/\/doi.org\/10.1093\/ndt\/gfv421.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"2209_CR62","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.113.005499","volume":"130","author":"JS Mathew","year":"2014","unstructured":"Mathew JS, Sachs MC, Katz R, Patton KK, Heckbert SR, Hoofnagle AN, et al. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). Circulation. 2014;130(4):298\u2013307. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005499.","journal-title":"Circulation"},{"issue":"5","key":"2209_CR63","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001082","volume":"3","author":"A Alonso","year":"2014","unstructured":"Alonso A, Misialek JR, Eckfeldt JH, Selvin E, Coresh J, Chen LY, et al. Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study. J Am Heart Assoc. 2014;3(5):e001082. https:\/\/doi.org\/10.1161\/JAHA.114.001082.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"2209_CR64","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/heartjnl-2016-309764","volume":"103","author":"L Lind","year":"2017","unstructured":"Lind L, Sundstr\u00f6m J, Stenemo M, Hagstr\u00f6m E, \u00c4rnl\u00f6v J. Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip. Heart. 2017;103(5):377\u201382. https:\/\/doi.org\/10.1136\/heartjnl-2016-309764.","journal-title":"Heart"},{"issue":"8","key":"2209_CR65","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/eci.12296","volume":"44","author":"YH Kao","year":"2014","unstructured":"Kao YH, Chen YC, Lin YK, Shiu RJ, Chao TF, Chen SA, et al. FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells. Eur J Clin Invest. 2014;44(8):795\u2013801. https:\/\/doi.org\/10.1111\/eci.12296.","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"2209_CR66","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1093\/ndt\/gfy392","volume":"34","author":"JA Navarro-Garc\u00eda","year":"2019","unstructured":"Navarro-Garc\u00eda JA, Delgado C, Fern\u00e1ndez-Velasco M, Val-Blasco A, Rodr\u00edguez-S\u00e1nchez E, Aceves-Ripoll J, et al. Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes. Nephrol Dial Transplant. 2019;34(11):1864\u201375. https:\/\/doi.org\/10.1093\/ndt\/gfy392.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2209_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00395-020-0810-6","volume":"115","author":"M Lindner","year":"2020","unstructured":"Lindner M, Mehel H, David A, Leroy C, Burtin M, Friedlander G, et al. Fibroblast growth factor 23 decreases PDE4 expression in heart increasing the risk of cardiac arrhythmia; Klotho opposes these effects. Basic Res Cardiol. 2020;115(5):51. https:\/\/doi.org\/10.1007\/s00395-020-0810-6.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"2209_CR68","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12882-019-1282-5","volume":"20","author":"ED Kim","year":"2019","unstructured":"Kim ED, Watt J, Tereshchenko LG, Jaar BG, Sozio SM, Kao WHL, et al. Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study. BMC Nephrol. 2019;20(1):133. https:\/\/doi.org\/10.1186\/s12882-019-1282-5.","journal-title":"BMC Nephrol"},{"issue":"3","key":"2209_CR69","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12013-014-9850-6","volume":"69","author":"C Gao","year":"2014","unstructured":"Gao C, Yang D. Electrical inhomogeneity in left ventricular hypertrophy. Cell Biochem Biophys. 2014;69(3):399\u2013404. https:\/\/doi.org\/10.1007\/s12013-014-9850-6.","journal-title":"Cell Biochem Biophys"},{"key":"2209_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jelectrocard.2019.12.007","volume":"59","author":"M Yener\u00e7a\u011f","year":"2020","unstructured":"Yener\u00e7a\u011f M, Arslan U. Tp-e interval and Tp-e\/QT ratio and their association with left ventricular diastolic dysfunction in Fabry disease without left ventricular hypertrophy. J Electrocardiol. 2020;59:20\u20134. https:\/\/doi.org\/10.1016\/j.jelectrocard.2019.12.007.","journal-title":"J Electrocardiol"},{"issue":"6","key":"2209_CR71","doi-asserted-by":"publisher","first-page":"H2283","DOI":"10.1152\/ajpheart.00798.2020","volume":"320","author":"JM Graves","year":"2021","unstructured":"Graves JM, Vallejo JA, Hamill CS, Wang D, Ahuja R, Patel S, et al. Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner. Am J Physiol Heart Circ Physiol. 2021;320(6):H2283\u201394. https:\/\/doi.org\/10.1152\/ajpheart.00798.2020.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"2209_CR72","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/2211-4122.143972","volume":"24","author":"A Khaledifar","year":"2014","unstructured":"Khaledifar A, Momeni A, Hasanzadeh K, Amiri M, Sedehi M. Association of corrected QT and QT dispersion with echocardiographic and laboratory findings in uremic patients under chronic hemodialysis. J Cardiovasc Echogr. 2014;24(3):78\u201382. https:\/\/doi.org\/10.4103\/2211-4122.143972.","journal-title":"J Cardiovasc Echogr"},{"issue":"11","key":"2209_CR73","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00467-012-2224-7","volume":"27","author":"W Seeherunvong","year":"2012","unstructured":"Seeherunvong W, Abitbol CL, Chandar J, Rusconi P, Zilleruelo GE, Freundlich M. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis. Pediatr Nephrol. 2012;27(11):2129\u201336. https:\/\/doi.org\/10.1007\/s00467-012-2224-7.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"2209_CR74","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1515\/jtim-2016-0030","volume":"4","author":"AA Nassiri","year":"2016","unstructured":"Nassiri AA, Hakemi MS, Safar-Pour R, Ahmadi A, Tohidi M, Kashani BS, et al. Association of serum intact fibroblast growth factor 23 with left ventricular mass and different echocardiographic findings in patients on hemodialysis. J Transl Int Med. 2016;4(3):135\u201341. https:\/\/doi.org\/10.1515\/jtim-2016-0030.","journal-title":"J Transl Int Med"},{"issue":"4","key":"2209_CR75","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/1744-9987.12087","volume":"17","author":"B Knap","year":"2013","unstructured":"Knap B, Ve\u010deri\u0107-Haler \u017d, Benedik M, Buturovi\u0107-Ponikvar J, Ponikvar R, Bren AF. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis. Ther Apher Dial. 2013;17(4):407\u201311. https:\/\/doi.org\/10.1111\/1744-9987.12087.","journal-title":"Ther Apher Dial"},{"issue":"8","key":"2209_CR76","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.hrthm.2007.05.028","volume":"4","author":"C Antzelevitch","year":"2007","unstructured":"Antzelevitch C, Sicouri S, Di Diego JM, Burashnikov A, Viskin S, Shimizu W, et al. Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm. 2007;4(8):1114\u20136; author reply 1116-1119. https:\/\/doi.org\/10.1016\/j.hrthm.2007.05.028.","journal-title":"Heart Rhythm"},{"issue":"12","key":"2209_CR77","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/europace\/euw033","volume":"18","author":"S Zumhagen","year":"2016","unstructured":"Zumhagen S, Zeidler EM, Stallmeyer B, Ernsting M, Eckardt L, Schulze-Bahr E. Tpeak-Tend interval and Tpeak-Tend\/QT ratio in patients with Brugada syndrome. Europace. 2016;18(12):1866\u201372. https:\/\/doi.org\/10.1093\/europace\/euw033.","journal-title":"Europace"},{"issue":"4","key":"2209_CR78","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.amjcard.2017.05.031","volume":"120","author":"SK Oskouie","year":"2017","unstructured":"Oskouie SK, Prenner SB, Shah SJ, Sauer AJ. Differences in repolarization heterogeneity among heart failure with preserved ejection fraction phenotypic subgroups. Am J Cardiol. 2017;120(4):601\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2017.05.031.","journal-title":"Am J Cardiol"},{"issue":"3","key":"2209_CR79","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly.35864","volume":"8","author":"A Monfared","year":"2016","unstructured":"Monfared A, Assadian Rad M, Feizkhah M, Kazemnezhad E, Esmaeili S, Rastjou Herfeh N, et al. Comparison of Tpe changing on ECG, in pre and post dialysis and post transplantation. Nephrourol Mon. 2016;8(3):e35864. https:\/\/doi.org\/10.5812\/numonthly.35864.","journal-title":"Nephrourol Mon"},{"key":"2209_CR80","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fphar.2020.00550","volume":"11","author":"KR Brewer","year":"2020","unstructured":"Brewer KR, Kuenze G, Vanoye CG, George AL, Meiler J, Sanders CR. Structures illuminate cardiac ion channel functions in health and in long QT syndrome. Front Pharmacol. 2020;11:550. https:\/\/doi.org\/10.3389\/fphar.2020.00550.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2209_CR81","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.gene.2016.07.069","volume":"593","author":"GW Abbott","year":"2016","unstructured":"Abbott GW. KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis. Gene. 2016;593(2):249\u201360. https:\/\/doi.org\/10.1016\/j.gene.2016.07.069.","journal-title":"Gene"},{"issue":"2","key":"2209_CR82","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1152\/physrev.00014.2006","volume":"87","author":"S Nattel","year":"2007","unstructured":"Nattel S, Maguy A, Le Bouter S, Yeh YH. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev. 2007;87(2):425\u201356. https:\/\/doi.org\/10.1152\/physrev.00014.2006.","journal-title":"Physiol Rev"},{"issue":"5","key":"2209_CR83","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/01.RES.83.5.560","volume":"83","author":"DM Barry","year":"1998","unstructured":"Barry DM, Xu H, Schuessler RB, Nerbonne JM. Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 alpha subunit. Circ Res. 1998;83(5):560\u20137. https:\/\/doi.org\/10.1161\/01.RES.83.5.560.","journal-title":"Circ Res"},{"key":"2209_CR84","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.3389\/fphys.2018.01186","volume":"9","author":"M Tamayo","year":"2018","unstructured":"Tamayo M, Martin-Nunes L, Val-Blasco A, Piedras MJ, Larriba MJ, G\u00f3mez-Hurtado N, et al. Calcitriol, the bioactive metabolite of vitamin D, increases ventricular K. Front Physiol. 2018;9:1186. https:\/\/doi.org\/10.3389\/fphys.2018.01186.","journal-title":"Front Physiol"},{"issue":"1","key":"2209_CR85","doi-asserted-by":"publisher","first-page":"40676","DOI":"10.1038\/srep40676","volume":"7","author":"AS Lee","year":"2017","unstructured":"Lee AS, Chen WY, Chan HC, Chung CH, Peng HY, Chang CM, et al. Electronegative LDL-mediated cardiac electrical remodeling in a rat model of chronic kidney disease. Sci Rep. 2017;7(1):40676. https:\/\/doi.org\/10.1038\/srep40676.","journal-title":"Sci Rep"},{"issue":"2","key":"2209_CR86","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0008-6363(97)00256-3","volume":"37","author":"AD Wickenden","year":"1998","unstructured":"Wickenden AD, Kaprielian R, Kassiri Z, Tsoporis JN, Tsushima R, Fishman GI, et al. The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res. 1998;37(2):312\u201323. https:\/\/doi.org\/10.1016\/S0008-6363(97)00256-3.","journal-title":"Cardiovasc Res"},{"issue":"Pt 1","key":"2209_CR87","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1113\/jphysiol.2005.086223","volume":"569","author":"SP Patel","year":"2005","unstructured":"Patel SP, Campbell DL. Transient outward potassium current, 'Ito', phenotypes in the mammalian left ventricle: underlying molecular, cellular and biophysical mechanisms. J Physiol. 2005;569(Pt 1):7\u201339. https:\/\/doi.org\/10.1113\/jphysiol.2005.086223.","journal-title":"J Physiol"},{"issue":"4","key":"2209_CR88","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/01.RES.79.4.669","volume":"79","author":"M Gidh-Jain","year":"1996","unstructured":"Gidh-Jain M, Huang B. Jain P, el-Sherif N: Differential expression of voltage-gated K+ channel genes in left ventricular remodeled myocardium after experimental myocardial infarction. Circ Res. 1996;79(4):669\u201375. https:\/\/doi.org\/10.1161\/01.RES.79.4.669.","journal-title":"Circ Res"},{"key":"2209_CR89","volume-title":"Vanthenapalli S","author":"JL Rodgers","year":"2020","unstructured":"Rodgers JL. Vanthenapalli S. Electrical remodeling and cardiotoxicity precedes structural and functional remodeling of mouse hearts under hyperoxia treatment. J Cell Physiol: Panguluri SK; 2020."},{"issue":"1","key":"2209_CR90","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ncomms2240","volume":"3","author":"J Xie","year":"2012","unstructured":"Xie J, Cha SK, An SW, Kuro-O M, Birnbaumer L, Huang CL. Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat Commun. 2012;3(1):1238. https:\/\/doi.org\/10.1038\/ncomms2240.","journal-title":"Nat Commun"},{"key":"2209_CR91","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.yjmcc.2019.11.149","volume":"138","author":"X Han","year":"2020","unstructured":"Han X, Cai C, Xiao Z, Quarles LD. FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice. J Mol Cell Cardiol. 2020;138:66\u201374. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.11.149.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"2209_CR92","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/1535370219894302","volume":"245","author":"PGA Suassuna","year":"2020","unstructured":"Suassuna PGA, Cherem PM, de Castro BB, Maquigussa E, Cenedeze MA, Lovisi JCM, et al. \u03b1Klotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats. Exp Biol Med (Maywood). 2020;245(1):66\u201378. https:\/\/doi.org\/10.1177\/1535370219894302.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"7","key":"2209_CR93","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol. 2010;160(7):1573\u20136. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00873.x.","journal-title":"Br J Pharmacol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02209-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02209-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02209-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:03:51Z","timestamp":1642557831000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02209-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2209"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02209-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study in patients was approved by the ethics committee of <i>Hospital Universitario 12 de Octubre<\/i> (CEI: 16\/250) and was conducted in compliance with the Declaration of Helsinki. All patients signed written informed agreement before the inclusion in the study.Experimental animal studies were performed following recommendations of the Spanish Animal Care and User Committee, according to the guidelines for ethical care and welfare (2013\/175) of experimental animals of the European Union (2010\/63\/EU) and following the ARRIVE guidelines for reporting experiments involving animals []. Animal studies were approved by the General Direction of Agriculture and the Environment at the Environment Council of Madrid (PROEX 053\/16, PROEX184\/17).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}